A woman in midlife talks with her clinician about hormone therapy and weight-loss medication

Hormone Therapy and GLP-1s: Can HRT Help Your Weight-Loss Medication Work Better?

September 23, 2026•9 min read

If you're taking a GLP-1 medication for weight loss — think semaglutide (Wegovy) or tirzepatide (Zepbound) — and you're also navigating menopause, you may have seen a headline lately suggesting the two go hand in hand. The short answer: a new, large study that will be presented later this month reports that midlife women who used menopause hormone therapy (HT) alongside a GLP-1 tended to lose more weight than those on the GLP-1 alone, and the signal was clearest with semaglutide. The full results haven't been published or peer-reviewed yet. But here's the important part: hormone therapy is not a weight-loss treatment, and this research is observational — it can point to a link, not prove a cause. Here's what the research actually shows, and what it's worth asking your clinician.

If you feel like every other woman you know has started asking about GLP-1 medications, you're not imagining it. Roughly 1 in 5 women ages 50 to 64 — about 20% — report current or past GLP-1 use, according to The Menopause Society, which describes this as the highest of any U.S. demographic group. At the same time, weight gain and changes in body shape are among the most common and most frustrating concerns women describe during the menopause transition. So when a study suggests hormone therapy might influence how well a weight-loss medication works, it's worth a careful look.

A woman in midlife reviews her health questions at home in warm morning light

What the new research actually found

The study that's making headlines is scheduled to be presented at The Menopause Society's annual meeting in San Diego, October 20–24, 2026. So far, only the society's advance press release is available, and the study has not been peer-reviewed. According to that release, the researchers looked at what they describe as the first known large real-world group of midlife women being treated for overweight or obesity: nearly 2,400 women taking semaglutide and nearly 1,500 taking tirzepatide, all over age 45 with a BMI over 27.

The headline finding: women using hormone therapy alongside semaglutide had significantly greater and sustained weight loss than those on semaglutide alone. For tirzepatide, hormone therapy users showed an early advantage, but that difference did not reach statistical significance by the end of the study — meaning researchers can't rule out that it was chance.

Lead author Dr. Regina Castaneda of the Mayo Clinic put it plainly: "We are seeing a consistent signal." The release also says the effect was stronger with semaglutide than with tirzepatide, that this difference needs further study, and that the authors consider the findings preliminary. Castaneda adds that it is "too early to draw firm conclusions."

Where this signal comes from

This isn't the first time researchers have spotted the pattern. It builds on smaller studies from Mayo Clinic researchers:

In a study published in The Lancet Obstetrics, Gynaecology, & Women's Health in January 2026, 120 postmenopausal women taking tirzepatide were compared. Those also using hormone therapy lost about 19.2% of their body weight on average, versus 14.0% for those not on hormone therapy. According to MedPage Today's coverage, that works out to roughly 35% more weight lost.
According to MedPage Today, the hormone therapy group was also more likely to reach bigger milestones: 45% of them lost at least 20% of their body weight, compared with 24% of non-users — and the gap widened at the 25% and 30% thresholds.
An earlier presentation of this work at the Endocrine Society's 2025 meeting reported similar results (17% versus 14% total weight loss). Dr. Castaneda said those data "are the first to show" that combining tirzepatide and hormone therapy significantly increases effectiveness, and noted that earlier semaglutide studies had found similar results.

Taken together, these are consistent but early signals — not proof.

Why might hormones and GLP-1s work together?

Researchers have suggested a possible biological link, but it is still a theory. A 2026 clinical review in Obesity Pillars notes that the menopause transition is associated with more body fat, including visceral fat (the deeper belly fat linked to heart and metabolic risk), and that this is primarily driven by estrogen deficiency. The same review says that observational data hint at a possible synergy between hormone therapy and obesity medications, but that these data are limited by small samples, a retrospective design and confounding (other differences between the women that could explain the results).

The fact that the effect looked stronger with semaglutide than with tirzepatide is itself interesting. Semaglutide acts on the GLP-1 pathway, while tirzepatide acts on both GLP-1 and a second pathway (GIP). Why the results differ is an open question for future studies, not a settled conclusion.

A woman at home reviewing her weekly routine in warm kitchen light

What hormone therapy is actually for — and what it isn't

Here's the part that's easy to misread in a headline, and it matters a lot.

Hormone therapy is not a weight-loss treatment. The sources we reviewed agree on this. The Menopause Society's own press release on this very study states plainly that "weight loss is not an indication for menopause hormone therapy" — meaning it shouldn't be prescribed for that purpose. A 2026 clinical review in the journal Obesity Pillars is equally direct: hormone therapy "should not be marketed or prescribed for weight loss or obesity treatment."

The American College of Obstetricians and Gynecologists (ACOG) adds useful color: the estrogen in hormone therapy may change where the body stores fat, but hormone therapy by itself won't cause weight loss. It may, however, help with the night sweats that wreck your sleep — and better sleep can make weight control easier.

So what is hormone therapy for? Its established uses are things like relieving moderate-to-severe hot flashes and night sweats, protecting against osteoporosis, and treating vulvovaginal symptoms. Any link to weight is something researchers are still sorting out.

What we still don't know

It's worth being honest about the limits here, because they're real:

These are observational studies, not randomized trials. They can show that women using hormone therapy lost more weight, but they can't prove the hormone therapy caused it.
The tirzepatide study was small (120 women) and overwhelmingly white (94%), which limits how far we can generalize.
The researchers themselves say the findings need to be confirmed in "adequately designed prospective trials" — and the lead author of the Lancet study has said the team plans to test the idea in a randomized clinical trial.

So the takeaway isn't "start hormone therapy to boost your weight loss." It's more like: this is an emerging, biologically plausible idea that researchers are actively testing — worth watching, and worth a conversation, but not a reason to change what you're doing.

What else could be going on

Weight struggles in midlife are rarely just one thing. Before assuming hormones (or a lack of them) explain everything, it can help to look at the whole picture. An underactive thyroid, insulin resistance, sleep apnea, certain medications, and chronic stress can all quietly affect weight — and any of them can coexist with menopause. That's exactly the kind of full-picture thinking we wrote about in our earlier post on menopause weight gain and "menopause belly", which first touched on the GLP-1 and hormone therapy question. This post is a deeper dive into that new angle, and a companion to that earlier piece.

Two women in midlife walking together outdoors and talking

Questions to ask your clinician

I'm on a GLP-1 (or considering one). Should we also talk about whether hormone therapy makes sense for my menopause symptoms?
Is hormone therapy an option for me at all, given my personal health history?
What are the known risks and benefits of hormone therapy for someone like me?
Besides hormones, what else might be affecting my weight that we should rule out (like thyroid or sleep)?
If I did start hormone therapy, how would we monitor how I'm responding?

Frequently asked questions

Does hormone therapy help you lose weight? On its own, no — hormone therapy is not a weight-loss treatment and isn't prescribed for that purpose. What early research suggests is that it may be linked to greater weight loss in women who are also taking a GLP-1 medication. That's a different, narrower claim.

Will hormone therapy make me gain weight? This is a common worry, but the research we reviewed doesn't point that way. ACOG notes that the estrogen in hormone therapy may change where the body stores fat, but that hormone therapy by itself won't lead to weight loss. A 2026 clinical review, citing randomized trials and meta-analyses, says hormone therapy may attenuate (lessen) central fat accumulation and preserve a favorable body composition.

Which GLP-1 medication works better with hormone therapy? The newest data, which hasn't been peer-reviewed yet, showed a clearer signal with semaglutide than with tirzepatide, but the researchers say this needs more study and isn't a reason to switch medications. Don't change your medication based on this early research.

Is this proven? No. The studies so far are observational, meaning they can't prove cause and effect. A randomized trial is planned. Treat this as an emerging area of research, not established guidance.

Should I start hormone therapy to boost my GLP-1 results? That's not what this research suggests doing. Hormone therapy should be considered for its own established reasons — like hot flashes or osteoporosis risk — and only after a personal risk-benefit conversation with a clinician.

Ready for answers that fit?

Weight, hormones, and medication decisions are personal — and they deserve more than a headline. If you want a clearer picture of what's actually going on with your body, start with our free Whole-Picture Check. Or talk with a licensed PresentHealth clinician who can help you sort through the options together.

This article is for education only and isn't a substitute for individualized medical care. GLP-1 medications and hormone therapy are prescription treatments that require a review of your personal health history, and any decision to start, stop, or change them should be made with a licensed clinician.